Greywolf Therapeutics

0 followers


Many cancers and other diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly.​ We're progressing first-in-class antigen modulators through the clinic, developed to treat disease by controlling T cell activation. Our technology modulates antigen presenta... Read more

Employees

11-50

Links


Org chart

Peter Joyce
Chief Executive Officer
Collapse
Andy Page
Chief Operating Officer/chief Business Officer
Tom Lillie
Chief Medical Officer
Paul Stainer
Vice President Finance And Business Development
Tom McCarthy
Founder & Chairperson
Darlene Deptula-Hicks
Chief Financial Officer

Teams

This company has no teams yet